Abstract
The spread of antimicrobial-resistant bacteria has become a serious public health problem worldwide. The existing antimicrobials are becoming obsolete and the development of new antimicrobials is at an extremely slow pace. It is necessary to invest in alternative approaches for the treatment of infections caused by these bacteria. One approach that can be explored is the use of antibodies…